By Mark DaCosta- As we honour the resilience and strength of women during International Women’s Month, it is essential to shed light on a pressing health issue that remains a significant threat to their well-being in our nation: cervical cancer. This disease, which is often linked to the Human Papillomavirus (HPV), is not only prevalent but also highly preventable. Thus, a concerted effort to raise awareness and promote early detection could save countless lives.
Cervical cancer arises when normal cells on the cervix, the lower segment of the uterus connected to the vagina, undergo harmful genetic transformations. These changes can lead to uncontrolled growth, culminating in the formation of a tumour. While cervical cancer is typically slow to progress, its lethal potential is amplified if diagnosed too late. In our country and throughout the Caribbean region, this cancer remains a leading cause of mortality among women, underscoring the urgent need for awareness and proactive screening measures.
At the heart of cervical cancer is HPV, a group comprising over 200 related viruses, most of which are common sexually transmitted infections. It is estimated that a majority of sexually active individuals will contract at least one strain of HPV in their lifetime, frequently without any indication of infection. However, the real concern lies with high-risk HPV strains, particularly HPV 16 and HPV 18. These strains can linger in the body for years, leading to abnormal changes in cervical cells, which may escalate to precancerous conditions or invasive cancer if left untreated.
Several factors can complicate a woman’s risk of developing cervical cancer. Those with compromised immune systems—whether due to certain medical conditions or medications—are less capable of eliminating HPV infections, which increases their vulnerability. Additionally, behaviours such as smoking can introduce harmful substances that negatively affect cervical cell DNA and immune function.
Early initiation of sexual activity and engagement with multiple partners can heighten exposure to high-risk HPV variants, while long-term use of oral contraceptives may also slightly raise the risk, albeit within the scope of their overall health benefits. Among the most critical risk factors is the lack of access to regular screening, such as Pap smears or HPV tests, which can hinder early detection.
One particularly insidious aspect of cervical cancer is its often asymptomatic nature in the initial stages. Due to this invisibility, many women may remain unaware of their condition until it is significantly advanced. Symptoms, when they do present, may include abnormal vaginal bleeding, unusual discharge, pelvic pain, or discomfort during intercourse. More advanced stages can manifest as swelling in the legs or unexplained back pain, further signalling the need for vigilant screening.
Detecting the disease early is paramount—this is where screenings play a vital role. Two primary methods exist for cervical cancer screening: the Pap smear, which identifies cellular changes in the cervix, and HPV DNA testing, which detects high-risk HPV strains. Important strides have been made in our nation to enhance accessibility to these screenings, advocating for every woman who has been sexually active to consult healthcare providers about their screening schedule, typically starting at ages 21 or 25 depending on local recommendations.
Among the most impactful advancements in the battle against cervical cancer is the introduction of the HPV vaccine. Vaccinating both girls and boys prior to exposure to HPV can significantly reduce the incidence of cervical cancer. In communities where the vaccine has been widely administered, this preventive measure holds the promise of dramatically decreasing both the prevalence and mortality associated with the disease.
Should a cervical cancer diagnosis occur, the treatment approach will largely depend on the stage of the illness. Options may include surgical interventions to remove cancerous tissues, radiation therapy, or chemotherapy.
The fight against cervical cancer need not be a losing battle. Through collective efforts, we can virtually eliminate this threat in our country. This International Women’s Month, let us commit ourselves to open discussions about HPV, encourage women to schedule regular screenings, and ensure that every individual has access to the essential information they need to safeguard their health. By raising awareness and understanding of the connection between HPV and cervical cancer, we lay the groundwork for a healthier future for our women and, indeed, our nation as a whole. Knowledge, in this case, truly serves as our most powerful form of defence.
